Scn2atm1.1Mfri
Targeted Allele Detail
|
|
| Symbol: |
Scn2atm1.1Mfri |
| Name: |
sodium channel, voltage-gated, type II, alpha; targeted mutation 1.1, Manuel A Friese |
| MGI ID: |
MGI:7779740 |
| Synonyms: |
Scn2aA263V |
| Gene: |
Scn2a Location: Chr2:65451115-65597791 bp, + strand Genetic Position: Chr2, 38.61 cM
|
| Alliance: |
Scn2atm1.1Mfri page
|
|
|
|
| Allele Type: |
|
Targeted (Humanized sequence) |
| Mutations: |
|
Insertion, Single point mutation
|
| |
|
Mutation details: Exon 7 was replaced with exon 7 containing human p.Ala263Val (A263V) gain-of-function mutation, a C to T substitution at position 788 (c.788C>T) and a loxP-flanked ACN cassette containing cre-recombinase under the control of the testes-specific promoter from the angiotensin-converting enzyme (tACE) and a Pol II-driven neomycin resistance gene. The tACE promoter allows expression of cre during spermatogenesis resulting in removal of the ACN cassette.
(J:355207)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Scn2a Mutation: |
94 strains or lines available
|
|
| Original: |
J:355207 Schattling B, et al., Activity of Na(V)1.2 promotes neurodegeneration in an animal model of multiple sclerosis. JCI Insight. 2016 Nov 17;1(19):e89810 |
| All: |
1 reference(s) |
|